For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information
New evidence
based knowledge
A key objective of NCCRED is to provide seed-funding to establish new clinical trials and clinical research, in order to build capacity for clinical research in the Alcohol and Other Drug (AOD) sector. Seed funding was granted through a formal application process with the level of funding determined by the NCCRED Board.
Rapid translation of forensic data from police drug seizures into clinical alerts to improve public health
Principal Investigator: Dr Monica Barratt, Royal Melbourne Institute of Technology.
Amount Awarded: $95,481.00
Rapid translation of forensic data from police drug seizures into clinical alerts to improve public health
Principal Investigator: Dr Monica Barratt, Royal Melbourne Institute of Technology.
Amount Awarded: $95,481.00
Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence
Principal Investigator: Prof Antonio Verdejo-Garcia, Monash University
Amount awarded: $94,369.00
Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence
Principal Investigator: Prof Antonio Verdejo-Garcia, Monash University
Amount awarded: $94,369.00
Detection of fever via wearable thermometers: An early intervention strategy to reduce the risk of drug-related toxicity at music festivals, a feasibility and acceptability study
Principal Investigator: Prof Andrew Dawson, University of Sydney.
Amount awarded: $95,000.00
Detection of fever via wearable thermometers: An early intervention strategy to reduce the risk of drug-related toxicity at music festivals, a feasibility and acceptability study
Principal Investigator: Prof Andrew Dawson, University of Sydney.
Amount awarded: $95,000.00
BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine
Principal Investigator: A/Prof Peter Kelly, University of Wollongong
Amount awarded: $61,342.00
BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine
Principal Investigator: A/Prof Peter Kelly, University of Wollongong
Amount awarded: $61,342.00
Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems.
Principal Investigator: A/Prof Suzanne Nielson, Monash University
Amount awarded: $98,774.00
Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems.
Principal Investigator: A/Prof Suzanne Nielson, Monash University
Amount awarded: $98,774.00
An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women
Principal Investigator: Dr Shalini Arunogiri, Turning Point, Eastern Health
Amount awarded: $97,844.25
An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women
Principal Investigator: Dr Shalini Arunogiri, Turning Point, Eastern Health
Amount awarded: $97,844.25
Risk communication for people who use MDMA/‘ecstasy’ and related drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts
Principal Investigator: Dr Amy Peacock, University of New South Wales
Amount awarded: $96,120.00
Risk communication for people who use MDMA/‘ecstasy’ and related drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts
Principal Investigator: Dr Amy Peacock, University of New South Wales
Amount awarded: $96,120.00
An open-label pilot study of sub-anaesthetic ketamine for methamphetamine abuse in young people.
Principal Investigator: Dr G Bedi, Orygen: The National Centre of Excellence in Youth Mental Health (Vic).
Amount awarded: $99,703.53.
An open-label pilot study of sub-anaesthetic ketamine for methamphetamine abuse in young people.
Principal Investigator: Dr G Bedi, Orygen: The National Centre of Excellence in Youth Mental Health (Vic).
Amount awarded: $99,703.53.
Methamphetamine and mutual support: a mixed methods exploration of SMART recovery participants’ characteristics and opportunities for enhanced referral pathways.
Principal Investigator: A/Prof P Kelly, University of Wollongong (NSW).
Amount awarded: $77,489.00.
Methamphetamine and mutual support: a mixed methods exploration of SMART recovery participants’ characteristics and opportunities for enhanced referral pathways.
Principal Investigator: A/Prof P Kelly, University of Wollongong (NSW).
Amount awarded: $77,489.00.
A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder.
Principal Investigator: A/Prof V. Manning, Monash University (Vic).
Amount awarded: $97,595.30.
A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder.
Principal Investigator: A/Prof V. Manning, Monash University (Vic).
Amount awarded: $97,595.30.
Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips.
Principal Investigator: Dr R.Sutherland, The University of New South Wales (NSW).
Amount awarded: $38,795.00.
Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips.
Principal Investigator: Dr R.Sutherland, The University of New South Wales (NSW).
Amount awarded: $38,795.00.
An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings.
Principal Investigator: A/Prof J. Ward, South Australian Health and Medical Research Institute (SA).
Amount awarded: $68,400.00.
An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings.
Principal Investigator: A/Prof J. Ward, South Australian Health and Medical Research Institute (SA).
Amount awarded: $68,400.00.
Round 1 Seed Funding and Capacity Building Grants Presentations
Recipients of Round 1 Seed Funding and Capacity Building Grants presented on their research at the 2019 NCCRED Symposium. You can view the Symposium program and watch the presentations on our website here
Emerging Drug Network of Australia (EDNA)
Principal Investigator: Dr J.Soderstrom, Royal Perth Hospital (WA)
Amount awarded: $100,000.00
Emerging Drug Network of Australia (EDNA)
Principal Investigator: Dr J.Soderstrom, Royal Perth Hospital (WA)
Amount awarded: $100,000.00
Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views
Principal Investigator: Dr B.Larance, University of Wollongong (NSW)
Amount awarded: $66,190.00.
Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views
Principal Investigator: Dr B.Larance, University of Wollongong (NSW)
Amount awarded: $66,190.00.
Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service
Principal Investigator: Dr C. Rodgers, St Vincent’s Hospital Sydney (NSW)
Amount awarded: $29,947.50
Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service
Principal Investigator: Dr C. Rodgers, St Vincent’s Hospital Sydney (NSW)
Amount awarded: $29,947.50
NCCRED awarded one round of Capacity building grants to existing investigator-initiated methamphetamine treatment research to expand clinical research capacity and national reach.
Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project
Principal Investigator: Prof N. Lintzeris, South Eastern Sydney Local Health District (NSW)
Amount awarded: $104,000.00
Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project
Principal Investigator: Prof N. Lintzeris, South Eastern Sydney Local Health District (NSW)
Amount awarded: $104,000.00
The LiMA@RPAH study: a randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence
Principal Investigator: Prof P.Haber, Royal Prince Alfred Hospital (NSW)
Amount awarded: $100,000.00
The LiMA@RPAH study: a randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence
Principal Investigator: Prof P.Haber, Royal Prince Alfred Hospital (NSW)
Amount awarded: $100,000.00
South Australian drug early warning system – Emergency Department admission blood psychoactive testing
Principal Investigator: Dr P.Stockham, Forensic Science SA (SA)
Amount awarded: $100,000.00
South Australian drug early warning system – Emergency Department admission blood psychoactive testing
Principal Investigator: Dr P.Stockham, Forensic Science SA (SA)
Amount awarded: $100,000.00
National Centre for Clinical
Research on Emerging Drugs
We would like to acknowledge the traditional owners of this country
and pay our respects to Elders past, present and emerging.